Clinical Trial Update: ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.

View source ↗

Summary

This observational study assesses the safety and effectiveness of bortezomib at first relapse after participation in HOVON-49/50 first-line trials for multiple …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Janssen-Cilag B.V. | Conditions: Multiple Myeloma, Hematological Neoplasms | Status: COMPLETED